Participantes
DIRECCIÓN
Miguel Martín
Professor of Medicine
Head of Medical Oncology Service
Instituto de Investigación Sanitaria Gregorio Marañón
Universidad Complutense de Madrid
SECRETARÍA
Aitana Calvo
Médico Adjunto
Hospital General Universitario Gregorio Marañón
PARTICIPANTES
Jesús Acebillo
Presidente del Grupo Novartis España
Carrie Bhang
TBC
John Scott Cameron
Clinical Program Leader in Novartis
Translational clinical research
Giordano Caponigro
Senior Director, Oncology Translational Research
Novartis Institutes for Biomedical Research
Cambridge, USA
Francisco Cervantes
Medico consultor senior, Servicio Hematología
Hospital Clinic, Barcelona
Andrew Chan
Colombian University Medical Centre
Manel Esteller
Director del Laboratorio de Epigenética del Cáncer Centro Nacional de Investigaciones Oncológicas, Madrid
Enriqueta Felip
Servicio de Oncología Médica. Hospital Vall d'Hebrón. Barcelona
Head, thoracic oncology unit
Andrew Kung
Professor of Pediatrics Columbia University Medical Center
Director of the Cancer Epigenetics and Biology Program (PEBL)
Bellvitge Institute for Biomedical Research
Bruce Levine
Director
Clinical Cell and Vaccine Production Facility
University of Pensylvania
Alberto Mantovani
Humanitas Research Hospital
Milano, Italy
Salvador Martín Algarra
Clínica Universitaria de Navarra
Eduardo Olavarría
Consultant Caematologist
Imperial College Healthcare NHS Trust of London
Andrés Poveda
Jefe de Sección del Servicio de Oncología Médica Fundación Instituto Valenciano de Oncología
Alfonso Quintás Cardama
Professor of Medicine Basel, Switzerland
Mark E. Robson
Clinical Director, Unical Genetics Service Memorial Sloan Kettering Cancer Center Nueva York (MSKCC)
Jesús San Miguel
Director de Medicina Clínica y Traslacional Universidad de Navarra
Stefan Scherer
Vice-president correlative science Novartis Oncology Global Development
Charles Swanton
Professor of Cancer medicine,
Director of Lung Cancer Centre of Excellence.
The Francis Crick Institute
Lincoln's Inn Fields Laboratory
Eric Van Cutsem
University Hospitals Gasthuisberg and KU Leuven
Programa
Miércoles, 22 Julio 2015
15:00
Welcome and introduction
Jesús Acebillo
Miguel Martín
15:15
Advances in Cancer Biology (1)
Epigenetics of cancer
Manel Esteller
Clinical impact of precision cancer medicine
Andrew Kung
16:35
Advances in Cancer Biology (2)
Genetic predisposition to breast cancer
Mark E. Robson
Inflammation and cancer: from bench to bedside
Alberto Mantovani
Jueves, 23 Julio 2015
09:00
Advances in Basic Science of Cancer: Clinical Applications
Introduction
Miguel Martín
Intratumor Heterogeneity and Cancer Evolution
Charles Swanton
Cancer Drug Resistance
John Scott Cameron
Reprogramming the Inmune System to treat Untreatable Cancers
Bruce Levine
Relevance of Cancer cell line Encyclopedias in drug development
Giordano Caponigro
11:30
Advances in Basic Science of Cancer: Clinical Applications (2)
CARTs
Alfonso Quintás Cardama
Clonal dynamics in response to cancer therapy using high-complexity barcoding.
Carrie Bhang
How clinical investigation is going to face the advances in science
Stefan Scherer
14:15
State of the Art in Cancer Management (1)
Introduction
Miguel Martín
State of the art in myeloproliferative disorders phi +.
Eduardo Olavarría
State of the art in myeloproliferative disorders Phi
Francisco Cervantes
State of the art in Multiple Myelama
Jesús San Miguel
Allogeneic Transplant for hematological malignancies: current indications.
Eduardo Olavarría
Viernes, 24 Julio 2015
09:00
State of the Art in Cancer Management (2)
Introduction
Aitana Calvo
State of the art in Melanoma
Salvador Martín Algarra
State of the art in Breast Cancer
Miguel Martín
State of the art in Lung cancer
Enriqueta Felip
Moderación: Miguel Martín
11:00
State of the Art in Cancer Management (3)
State of art in Gynecological malignancies
Andrés Poveda
State of the art in GI Cancers
Eric Van Cutsem
Molecular genetics of human Colorectal
Andrew Chan
13:30
Closing remarks
Miguel Martín
Sin fecha definida
Advances in Cancer Biology (2)
Advances in Cancer Biology (1)
Advances in Basic Science of Cancer: Clinical Applications
State of the Art in Cancer Management (1)
State of the Art in Cancer Management (2)
State of the Art in Cancer Management (3)
Advances in Basic Science of Cancer: Clinical Applications (2)
